Correction to: British Journal of Cancer (2009) 100, 1444–1451. doi:10.1038/sj.bjc.6605020
Upon publication of this paper in 2009, the authors noticed two errors – one in the abstract and one within the Results section.
On page 1444 (Abstract), the seventh sentence should read as follows:
‘In a combining analysis, patients with a CXCR7high/CXCR4high tumour had a significantly shorter DFS and OS than patients with a CXCR4low/CXCR7low tumour’.
On page 1447 (Results), the first sentence of the section entitled ‘CXCR4 and CXCR7 coexpression and patients outcome’ should read as follows:
‘Interestingly, patients with CXCR4low/CXCR7low tumour expression have a significantly prolonged DFS and OS than those patients with a CXCR4high/CXCR7high tumour expression (Figure 3C; median DFS: 15.80 months (95% CI: 10.43–21.17) vs 7.62 (2.97–12.27), P=0.037; median OS: not reached vs 9.69 (95% CI: 5.13–14.07), P=0.001)’.
Change history
29 March 2012
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/sj.bjc.6605020
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Maréchal, R., Demetter, P., Nagy, N. et al. Erratum: High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. Br J Cancer 103, 930 (2010). https://doi.org/10.1038/sj.bjc.6605894
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6605894
